Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127783631 | 12778363 | 1 | I | 20160919 | 20160926 | 20160926 | EXP | KR-ROCHE-1833475 | ROCHE | YOON H, KOOM W, KIM T, AHN J. JUNG M, KIM T, KIM H, SHIN S AND KIM N UPFRONT SYSTEMIC CHEMOTHERAPY AND SHORT- COURSE RADIOTHERAPY WITH DELAYED SURGERY FOR LOCALLY ADVANCED RECTAL CANCER WITH DISTANT METASTASES: OUTCOMES, COMPLIANCE, AND FAVORABLE PROGNOSTIC FACTORS. PLOS ONE 2016 AUG;11 (8):1-14. | 0.00 | Y | 0.00000 | 20160926 | OT | KR | KR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127783631 | 12778363 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Unknown | U | 125085 | ||||||||||
| 127783631 | 12778363 | 2 | SS | CETUXIMAB | CETUXIMAB | 1 | Unknown | U | 0 | ||||||||||
| 127783631 | 12778363 | 3 | SS | 5-FLUOROURACIL | FLUOROURACIL | 1 | Unknown | U | 0 | ||||||||||
| 127783631 | 12778363 | 4 | SS | LEUCOVORIN. | LEUCOVORIN | 1 | Unknown | U | 0 | ||||||||||
| 127783631 | 12778363 | 5 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Unknown | U | 0 | ||||||||||
| 127783631 | 12778363 | 6 | SS | IRINOTECAN | IRINOTECAN | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127783631 | 12778363 | 1 | Rectal cancer |
| 127783631 | 12778363 | 2 | Rectal cancer |
| 127783631 | 12778363 | 3 | Rectal cancer |
| 127783631 | 12778363 | 4 | Rectal cancer |
| 127783631 | 12778363 | 5 | Rectal cancer |
| 127783631 | 12778363 | 6 | Rectal cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127783631 | 12778363 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127783631 | 12778363 | Diarrhoea | |
| 127783631 | 12778363 | Haematotoxicity | |
| 127783631 | 12778363 | Mucosal inflammation | |
| 127783631 | 12778363 | Nausea | |
| 127783631 | 12778363 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |